Device
TauroPace™
TauroPace™ is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
Completed1
Active, not recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Trials by Status
completed133%
active_not_recruiting133%
unknown133%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruiting
European TauroPace Registry - University of Schleswig-Holstein Prospective Observational Clinical Study
NCT04735666
completed
Taurolidine Containing Antimicrobial CIED Wash to Prevent Infection
NCT05576194
unknown
Tauropace to Prevent Cardiac Implantable Device Infections in Heart Failure Patients
NCT05103267
Clinical Trials (3)
Showing 3 of 3 trials
NCT04735666
European TauroPace Registry - University of Schleswig-Holstein Prospective Observational Clinical Study
NCT05576194
Taurolidine Containing Antimicrobial CIED Wash to Prevent Infection
NCT05103267
Tauropace to Prevent Cardiac Implantable Device Infections in Heart Failure Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3